Kidney dialysis drug data boost Keryx’s hopes for U.S. approval

Keryx Biopharmaceuticals, which just opened a Boston office this spring, has gotten a boost in its hopes for approval of its kidney dialysis drug from a leading medical journal...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.